They are not the first to offer this. Maybe in the US but you can do this easily with minimal effort in Germany. And I think they don’t have that much time till

They are not the first to offer this. Maybe in the US but you can do this easily with minimal effort in Germany. And I think they don’t have that much time till it will be „mainstream „ for every patient. Genome sequencing has become so cheap in recent years (and will be much cheaper in the next few years) that everyone who wants it will simply get it. Against the background of personalized medicine, this is also very useful. (My background: CEO of a company for personalized cancer therapy through WGS) https://www.bundesgesundheitsministerium.de/en/en/international/european-health-policy/genomde-en https://www.bundesgesundheitsministerium.de/en/en/internatio...